As Medicare price negotiations roll on, drugmakers counter HHS' initial offers
As Medicare price negotiations roll on, drugmakers counter HHS' initial offers zbecker Mon, 03/04/2024 - 15:35
As Medicare price negotiations roll on, drugmakers counter HHS' initial offers zbecker Mon, 03/04/2024 - 15:35
RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds zbecker Mon, 03/04/2024 - 11:12
With Takeda out of the picture, J&J’s Rybrevant moves into first line in lung cancer subtype aliu Mon, 03/04/2024 - 10:45
Perrigo's over-the-counter birth control launch takes flight in the US fkansteiner Mon, 03/04/2024 - 10:37
Pfizer stops buildout of $350M Seagen plant, leaving 120 workers' roles in question kdunleavy Mon, 03/04/2024 - 10:24
After multiple wrist-slaps, Aurobindo unit Eugia receives another manufacturing write-up fkansteiner Mon, 03/04/2024 - 09:43